University of Colorado, Denver: Opioid-Related Disorders trials

The registry lists 13 Opioid-Related Disorders studies with University of Colorado, Denver as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 7No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Improving Hospital-To-Methadone Clinic Connection Using Implementation Support for Patients With Opioid Use DisorderNot yet recruitingNCT07568847Not applicable
• Evaluation of Clinical Decision Support in Opioid TaperingNot yet recruitingNCT06527079
• Clinical Decision Support to Increase Use of Medications for Opioid Use DisorderRecruitingNCT06526286
• A Multi-site Intervention to Expand Hospital Based OUD Treatment ProvisionCompletedNCT06291090Not applicable
• Reducing Pain and Opioid Use With CBDCompletedNCT05299944Phase 2
• Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use DisorderActive, not recruitingNCT04664062Not applicable
• Advancing STOP: Self-regulation Therapy for Opioid Addiction and PainCompletedNCT03363243Not applicable
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6WithdrawnNCT00000331Phase 2
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5WithdrawnNCT00000330Phase 2
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4WithdrawnNCT00000329Phase 2
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3WithdrawnNCT00000328Phase 2
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2WithdrawnNCT00000327Phase 2
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1WithdrawnNCT00000326Phase 2